Drug Use Investigation for XYZAL
Phase of Trial: Phase IV
Latest Information Update: 20 Aug 2015
At a glance
- Drugs Levocetirizine (Primary)
- Indications Perennial allergic rhinitis; Seasonal allergic rhinitis
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 07 Jul 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 07 Jun 2013 Planned End Date changed from 1 Apr 2013 to 1 Nov 2013 as reported by ClinicalTrials.gov.
- 05 Oct 2011 New trial record